α-catenin. A tumor suppressor beyond adherens junctions
- PMID: 25483184
- PMCID: PMC4128878
- DOI: 10.4161/cc.29765
α-catenin. A tumor suppressor beyond adherens junctions
Abstract
Downregulation or loss of α-catenin occurs in multiple human cancer types. The traditional view of α-catenin is that it is one of the core components of the E-cadherin-catenin complex and is required for maintaining the integrity of the intercellular adherens junction, a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. Therefore, loss of α-catenin can result in loss of cell-cell adhesion, a common characteristic of cancer cells. There is an emerging recognition; however, that α-catenin also regulates multiple signaling pathways independent of adherens junctions. For instance, α-catenin functions as a tumor suppressor in E-cadherin-negative basal like breast cancer cells by inhibiting NF-κB signaling. In this perspective, we discuss the role and mechanisms of α-catenin in regulating several signaling pathways in cancer.
Keywords: Hedgehog; NF-kB; YAP; cancer; tumor suppressor; α-catenin; β-catenin.
Figures

Similar articles
-
DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity.Mol Cell Biol. 2012 Jun;32(11):2145-59. doi: 10.1128/MCB.06580-11. Epub 2012 Apr 2. Mol Cell Biol. 2012. PMID: 22473989 Free PMC article.
-
alpha-catenin mechanosensing for adherens junctions.Nat Cell Biol. 2010 Jun;12(6):522-4. doi: 10.1038/ncb2066. Epub 2010 May 9. Nat Cell Biol. 2010. PMID: 20453846
-
Alpha T-catenin: a crucial tumor suppressor in cancer pathogenesis.J Mol Histol. 2024 Oct;55(5):655-660. doi: 10.1007/s10735-024-10232-2. Epub 2024 Jul 31. J Mol Histol. 2024. PMID: 39083160 Review.
-
Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties.Oncogene. 2012 Aug 9;31(32):3709-20. doi: 10.1038/onc.2011.529. Epub 2011 Dec 12. Oncogene. 2012. PMID: 22158051
-
Can 1000 reviews be wrong? Actin, alpha-Catenin, and adherens junctions.Cell. 2005 Dec 2;123(5):769-72. doi: 10.1016/j.cell.2005.11.009. Cell. 2005. PMID: 16325573 Review.
Cited by
-
Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385. Curr Issues Mol Biol. 2024. PMID: 39057027 Free PMC article. Review.
-
Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.Sci Rep. 2020 Jan 22;10(1):1003. doi: 10.1038/s41598-020-57942-7. Sci Rep. 2020. PMID: 31969654 Free PMC article.
-
Impaired formation of homotypic cell-in-cell structures in human tumor cells lacking alpha-catenin expression.Sci Rep. 2015 Jul 20;5:12223. doi: 10.1038/srep12223. Sci Rep. 2015. PMID: 26192076 Free PMC article.
-
Genome-wide screening for genetic variants in polyadenylation signal (PAS) sites in mouse selection lines for fatness and leanness.Mamm Genome. 2023 Mar;34(1):12-31. doi: 10.1007/s00335-022-09967-8. Epub 2022 Nov 21. Mamm Genome. 2023. PMID: 36414820 Free PMC article.
-
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.Front Oncol. 2024 Oct 10;14:1431418. doi: 10.3389/fonc.2024.1431418. eCollection 2024. Front Oncol. 2024. PMID: 39450256 Free PMC article. Review.
References
-
- Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508–17. doi: 10.1136/jmg.2004.018275. - DOI - PMC - PubMed
-
- Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink J, Krimpenfort P, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006;10:437–49. doi: 10.1016/j.ccr.2006.09.013. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources